ES2058073T3 - Derivados de 5-fluorouracilo. - Google Patents

Derivados de 5-fluorouracilo.

Info

Publication number
ES2058073T3
ES2058073T3 ES87106264T ES87106264T ES2058073T3 ES 2058073 T3 ES2058073 T3 ES 2058073T3 ES 87106264 T ES87106264 T ES 87106264T ES 87106264 T ES87106264 T ES 87106264T ES 2058073 T3 ES2058073 T3 ES 2058073T3
Authority
ES
Spain
Prior art keywords
same
fluorouracilo
derivatives
hydrogen atom
against cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87106264T
Other languages
English (en)
Spanish (es)
Inventor
Setsuro Aig De Blanche Fujii
Mitsuru Hirohashi
Yoshihito Yamamoto
Yutaka Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2058073T3 publication Critical patent/ES2058073T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES87106264T 1986-04-30 1987-04-29 Derivados de 5-fluorouracilo. Expired - Lifetime ES2058073T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10128586 1986-04-30
JP4575487 1987-02-27

Publications (1)

Publication Number Publication Date
ES2058073T3 true ES2058073T3 (es) 1994-11-01

Family

ID=26385819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87106264T Expired - Lifetime ES2058073T3 (es) 1986-04-30 1987-04-29 Derivados de 5-fluorouracilo.

Country Status (9)

Country Link
US (1) US5047521A (enExample)
EP (1) EP0247381B1 (enExample)
JP (1) JPH07103112B2 (enExample)
KR (1) KR950002161B1 (enExample)
DE (1) DE3786834T2 (enExample)
DK (1) DK166088C (enExample)
ES (1) ES2058073T3 (enExample)
GB (1) GB2200352B (enExample)
WO (1) WO1987006582A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
AU610913B2 (en) * 1987-07-31 1991-05-30 Taiho Pharmaceutical Co., Ltd. 2'-deoxy-5-fluorouridine derivatives
US4992534A (en) * 1987-08-12 1991-02-12 Otsuka Pharmaceutical Co., Ltd. 3'-O-,5'-O-derivatives of 2'-deoxy-5-fluorouridine
KR20050109505A (ko) * 2003-02-22 2005-11-21 메르크 파텐트 게엠베하 액정인 시아노피리돈 유도체
EP1631301A4 (en) * 2003-05-20 2006-06-07 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH 5-FLUOROURACIL OR A DERIVATIVE AND A LIPOSOMAL PLATIN COMPLEX
JP2007077109A (ja) * 2005-09-16 2007-03-29 Tokyo Institute Of Technology ヌクレオシド誘導体及びその製造方法
US7561776B2 (en) * 2005-11-29 2009-07-14 Petrospec Engineering Ltd. Method of preventing hydrogen darkening of optic fibre
AU2013203591B2 (en) * 2009-05-01 2017-01-19 University Court Of The University Of Dundee Treatment or prophylaxis of proliferative conditions
GB0907551D0 (en) * 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
PT2495243T (pt) * 2009-10-27 2017-03-13 Delta-Fly Pharma Inc Novos derivados de 5-fluoruracilo
EP3746134A1 (en) 2018-02-02 2020-12-09 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124765A (en) * 1975-05-13 1978-11-07 Ono Pharmaceutical Co., Ltd. 5-Fluorouracil derivatives
JPS6011704B2 (ja) * 1976-07-30 1985-03-27 大鵬薬品工業株式会社 5−フルオルウラシル誘導体の製造法
JPS5379879A (en) * 1976-12-23 1978-07-14 Mitsui Toatsu Chem Inc 1,3-substituted-5-fluorouracils and process for their preparation
DE2658672A1 (de) * 1976-12-23 1978-06-29 Robugen Gmbh Neue nucleosid-verbindungen und verfahren zu ihrer herstellung
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体の製造法
JPS5535057A (en) * 1978-09-05 1980-03-11 Funai Corp 2'-deoxy-5-fluorouridine derivative, its preparation, and antitumor agent comprising it
US4340728A (en) * 1979-11-28 1982-07-20 Fuji Kagaku Kogyo Kabushiki Kaisha Nucleoside derivatives and process for preparing same
GB2072164B (en) * 1980-02-15 1983-12-21 Funai Pharmaceutical Ind Ltd 2'-deoxy-3',5'-di-o-alkylcarbonyl-5-fluorouridine derivatives a process for the preparation of the derivatives and antitumor agents containing the derivatives
JPS5929699A (ja) * 1982-08-11 1984-02-16 Funai Corp 2′−デオキシ−5−フルオロウリジンのエ−テル誘導体およびその製造方法並びにこれを含有する抗腫瘍剤
JPS58185522A (ja) * 1983-02-28 1983-10-29 Toyama Chem Co Ltd 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体
KR860001865B1 (ko) * 1983-05-23 1986-10-24 다이호야꾸힝 고오교 가부시끼가이샤 2'-데옥시-5-치환 우리딘 유도체의 제조방법
JPS6061593A (ja) * 1983-09-14 1985-04-09 Taiho Yakuhin Kogyo Kk 2’−デオキシ−5−トリフルオロメチルウリジン誘導体及びそれを含む抗腫瘍剤
WO1985000608A1 (fr) * 1983-07-20 1985-02-14 Teijin Limited Agent antineoplastique
US4515618A (en) * 1983-12-07 1985-05-07 Chevron Research Company 5-Deoxy-3-O-thienylmethyl or furylmethyl-1,2-O-alkylidene-alpha-D-xylofuranose herbicide derivatives
EP0180188B1 (en) * 1984-10-30 1992-04-15 Otsuka Pharmaceutical Co., Ltd. A composition for increasing the anti-cancer activity of an anti-cancer compound
AU610913B2 (en) * 1987-07-31 1991-05-30 Taiho Pharmaceutical Co., Ltd. 2'-deoxy-5-fluorouridine derivatives
US4992534A (en) * 1987-08-12 1991-02-12 Otsuka Pharmaceutical Co., Ltd. 3'-O-,5'-O-derivatives of 2'-deoxy-5-fluorouridine
JPH02187484A (ja) * 1989-01-13 1990-07-23 Okitsumo Kk 紙用瞬間接着剤

Also Published As

Publication number Publication date
DK691287D0 (da) 1987-12-29
DE3786834T2 (de) 1994-03-03
EP0247381A2 (en) 1987-12-02
US5047521A (en) 1991-09-10
EP0247381A3 (en) 1988-11-23
JPH07103112B2 (ja) 1995-11-08
DK166088C (da) 1993-08-23
WO1987006582A1 (fr) 1987-11-05
DE3786834D1 (de) 1993-09-09
EP0247381B1 (en) 1993-08-04
GB2200352A (en) 1988-08-03
JPH07103112B1 (enExample) 1995-11-08
DK166088B (da) 1993-03-08
DK691287A (da) 1988-02-19
GB2200352B (en) 1990-07-25
KR880701232A (ko) 1988-07-26
KR950002161B1 (ko) 1995-03-14
GB8730031D0 (en) 1988-02-03

Similar Documents

Publication Publication Date Title
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
ES2058073T3 (es) Derivados de 5-fluorouracilo.
ES316768A1 (es) Procedimiento para la preparacion de una nueva poliamida.
CO4130326A1 (es) Nuevos derivados de 2-ciano-1,3-diona, composiciones que los contienen, procedimientos para su preparacion y su uso como herbicidas
SE7409654L (enExample)
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR246160A1 (es) Preservativo para composiciones acuosas.
ES8601850A1 (es) Un procedimiento para preparar derivados de ciclobutano
ES466436A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3-(2-aril-2-propil)urea.
ES8603752A1 (es) Procedimiento de preparacion de una composicion tintorea para la coloracion directa de fibras queratinicas
KR880006984A (ko) 식물 웅성 불음제
ES422906A1 (es) Un procedimiento para preparar nuevos derivados de 2-amino-indano.
ES2064748T3 (es) Composiciones antiviricas conteniendo derivados del sulfoquinovosil glicerol y analogos del mismo y su uso.
DK260180A (da) Pseudotrisaccharider deres fremstilling og anvendelse som antibakterielle midler
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
ES419381A1 (es) Un procedimiento para la preparacion de nuevos derivados de2-amino (1,2,3,4-tetrahidronaftaleno).
DK351982A (da) Fremgangsmaade til fremstilling af aminoglycosidderivater
DK126113B (da) Ethere af Δ<1,3,5(10)>-ostratrien-3-ol eller 3-ethere eller 3-estere deraf til anvendelse som svangerskabsforebyggende midler.
SE7609229L (sv) Medel for selektiv ogresbekempning i betor
ES8800262A1 (es) Procedimiento de preparacion de 21-hidroxi-20-ceto-delta16-esteroides
GB889706A (en) Fungicidal composition
ES2128529T3 (es) Derivados de oxazolina, procedimiento para su preparacion y composiciones agricolas y horticolas para el control de organismos nocivos que los contienen.
ES2059769T3 (es) Composiciones veterinarias para usar contra endoparasitos y su preparacion.
GT198500070A (es) Composiciones sinergicas pesticidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 247381

Country of ref document: ES